Autolus Therapeutics plc ADR (AUTL) has a current stock price of $2.39. During the previous trading session, the stock witnessed a notable rise, reaching a high of $13.0 after opening at $2.44. The stock’s low for the day was $5.8, and it eventually closed at $2.49.
Autolus Therapeutics plc ADR’s stock market performance has been consistent.
52-week price history of AUTL Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Autolus Therapeutics plc ADR’s current trading price is -52.10% away from its 52-week high, while its distance from the 52-week low is 116.74%. The stock’s price range during this period has fluctuated between $1.11 and $5.00. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.33 million for the day, which was evidently lower than the average daily volume of 2.11 million over the last three months.
Financial Performance and Market Capitalization
Autolus Therapeutics plc ADR (AUTL) has experienced a quarterly rise of 69.86% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 637.41M and boasts a workforce of 647 employees.
Analysts’ Ratings For Autolus Therapeutics plc ADR
As of right now, 9 analysts are rating Autolus Therapeutics plc ADR as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.85, with a change in price of +0.39. Similarly, Autolus Therapeutics plc ADR recorded 1,992,590 in trading volume during the last 100 days, posting a change of +19.65%.
AUTL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AUTL stands at 0.84. Similarly, the long-term debt-to-equity ratio is also 0.83.
AUTL Stock Stochastic Average
Autolus Therapeutics plc ADR’s raw stochastic average for the past 50 days is currently at 76.49%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 36.56%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 45.32% and 52.11%, respectively.
AUTL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -48.27% this year. Over the last six months, there has been a weaker performance of 11.92%. The price of AUTL fallen by 4.59% during the last 30 days period. For the last 5-days stocks have slided -9.28%.
